

We, also on behalf of the Fit4MedRob Consortium, read with great interest your Editorial on neurorehabilitation,1 and strongly endorse its call to centre rehabilitation on individual needs and to close the post-discharge care gap across the continuum of care. In this spirit, we wish to draw attention to Fit for Medical Robotics (Fit4MedRob)—an Italian initiative funded by the Italian Ministry of University and Research (total cost of approximately €120 million) that directly addresses the priorities highlighted by the Editorial.
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet